This expert interview with Robert E. Coleman, MD, FRCP, from the Cancer Research Centre, Weston Park Hospital NHS Trust, Sheffield, United Kingdom, and special newsflash, discusses the topic of bone metastases in breast cancer focusing on the following data release:

Abstract #2LBA: Denosumab versus zoledronic acid for the treatment of breast cancer patients with bone metastases: results of a randomized phase 3 study

View the eNewsflash from this data release

This expert interview with José Baselga, MD, from the Vall d'Hebron University Hospital, Barcelona, Spain, and special newsflash, discusses the topic of novel regimens in advanced breast cancer focusing on the following data release:

Abstract #3LBA: SOLTI-0701: A double-blind, randomized phase 2b study evaluating the efficacy and safety of sorafenib (SOR) compared to placebo (PL) when administered in combination with capecitabine (CAP) in patients (pts) with locally advanced (adv) or metastatic (met) breast cancer (BC)

View the eNewsflash from this data release

This expert interview with Marcia Brose, MD, PhD, from the Abramson Cancer Center of the University of Pennsylvania, Philadelphia, United States, discusses the topic of targeted therapy in advanced thyroid cancer focusing on the following data release:

Abstract #51LBA: Completion of a phase II study of sorafenib for advanced thyroid cancer

View the Expert Interview and opinion with Marcia Brose, MD, PhD, and Lee Lokey, MD